Novo Nordisk A/S (NYSE:NVO)

44.84
Delayed Data
As of Jun 15
 +0.19 / +0.43%
Today’s Change
41.03
Today|||52-Week Range
58.37
-16.45%
Year-to-Date

Today’s Trading

Previous close44.65
Today’s open44.71
Day’s range44.56 - 45.07
Volume2,073,608
Average volume (3 months)1,552,562
Market cap$92.8B
Data as of 4:03pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)+6.29%
Earnings growth (this year)+3.34%
Earnings growth (next 5 years)+6.02%
Revenue growth (last year)+3.25%
P/E ratio18.3
Price/Sales7.77
Price/Book15.20

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.05-0.08%
LLYEli Lilly and Co+0.53+0.61%
BMYBristol-Myers Squibb+1.17+2.18%
GSKGlaxoSmithKline-0.50-1.19%
Data as of 4:04pm ET, 06/15/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$0.66
Annual revenue (last year)$17.1B
Annual profit (last year)$5.8B
Net profit margin34.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts